{
 "id": "pulmonary-hypertension",
 "name": "Pulmonary Hypertension",
 "aliases": [
  "Pulmonary hypertension"
 ],
 "acronyms": [],
 "bodySystem": "cardiovascular",
 "parent": null,
 "children": [
  "pulmonary-arterial-hypertension"
 ],
 "edition": "2026-11",
 "merkleRoot": "006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6",
 "builtFrom": "program.status and program.eligibility facts, grouped by the condition registry",
 "counts": {
  "open": 2,
  "limited": 0,
  "waitlist": 0,
  "closed": 0
 },
 "funds": [
  {
   "fund": "Pulmonary Hypertension - Medicare Access",
   "organization": "HealthWell Foundation",
   "status": "open",
   "dateOnPage": null,
   "awardLevelUsd": null,
   "insuranceTypes": null,
   "pageSays": "The page lists the fund as Open.",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  },
  {
   "fund": "Pulmonary hypertension",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "open",
   "dateOnPage": null,
   "awardLevelUsd": 9500,
   "insuranceTypes": [
    "Any health insurance"
   ],
   "pageSays": "The page lists the fund as Open.",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  }
 ],
 "drugsWhoseLabelNamesThisCondition": [
  {
   "ingredient": "Riociguat",
   "pages": [
    {
     "brand": "Adempas",
     "url": "https://omnirx.org/medicines/adempas"
    }
   ],
   "labelSentence": "Persistent/recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%227b57509a-3d5d-41d4-8fed-1471e26372a3%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Bayer US Patient Assistance Foundation",
     "url": "https://www.patientassistance.bayer.us/en/about/bayer-products",
     "programPageIsExternal": true,
     "inCurrentList": true,
     "note": null,
     "listKind": "Bayer prescription medicines included in the program",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Treprostinil",
   "pages": [
    {
     "brand": "Tyvaso Dpi",
     "url": "https://omnirx.org/medicines/tyvaso-dpi"
    }
   ],
   "labelSentence": "Pulmonary hypertension associated with interstitial lung disease (PH-ILD;",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22cbc31ab1-a80f-4b50-a3b1-39910b0fb609%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [],
   "medicareNegotiatedPrice": null
  }
 ],
 "fundsForRelatedCosts": [],
 "note": "Each status is what the fund page said on readOn. It is not an eligibility determination. We hold only the organizations we read; no fund here does not mean no fund exists.",
 "licence": "CC BY 4.0 for the OmniRx compilation"
}